The CDC first recommended annual flu shots for all children 6 months and older in 2008, when it expanded the recommendation ...

Swansea experts have carried out the largest ever comparison of wellbeing-focused interventions delivered to adults. They reviewed 183 randomized controlled trials, representing almost 23,000 ...

The press release promoting the study asserts that “universal SEL programs are a sound investment in education systems ...

In today's healthcare environment, securing regulatory approval is only the beginning. The real challenge lies in ensuring ...

This week, Mad in America examines recent antidepressant research questioning withdrawal severity, a study of unsupported ...

AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.

In response, the government in November released the guidebook In Case of Crisis: Taiwan’s National Public Safety Guide (the “Orange Book”) and distributed it to every household. The handbook aims to ...

Digital health platforms improve pediatric care by offering customized, interactive tools for children and parents. They enhance education, support, and engagement while tackling challenges related to ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

Arc Raiders has an incredibly bright future — it's likely already won the 2026 extraction shooter arms race — but if existing ...